Vaccine composition and immunization method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8968749
APP PUB NO 20140255448A1
SERIAL NO

14288361

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSIDADE FEDERAL DE MINAS GERAIS - UFMGAV ANTÔNIO CARLOS 6627 - UNIDADE ADMINISTRATIVA 2º ANDAR - SALA 2011 BELO HORIZONTE 31270-901

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abrantes, Christiane De Freitas Belo Horizonte, BR 2 4
Coelho, Eduardo Antonio Ferraz Belo Horizonte, BR 3 4
Fernandes, Ana Paula Salles Moura Belo Horizonte, BR 3 4
Gazzinelli, Ricardo Tostes Belo Horizonte, BR 8 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00